For those with Hodgkin lymphoma, brentuximab vedotin may increase overall survival
The study's findings were presented by Stephen Ansell, M.D., Ph.D., at the ASCO Annual Meeting in Chicago in…
The study's findings were presented by Stephen Ansell, M.D., Ph.D., at the ASCO Annual Meeting in Chicago in…